Metraipolis › archive › dc_4e1ca8dd93bc

Biomimetic Nanocarriers for Glioblastoma Therapy: Translational Advances and Strategic Challenges — Europe PMC PMID:42794948

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42794948
DOI: 10.3390/cancers18182982
License (as archived): solo-consultazione
Archived: 2026-10-15T15:18:17.488Z
SHA-256 of the archived text: 5280b558a6cfcfaeb089db219c6bd95190d86c3e7eb66f032734305ea3526fa4
Stable URL of this page: https://metraipolis.com/documento/dc_4e1ca8dd93bc

How to cite

Biomimetic Nanocarriers for Glioblastoma Therapy: Translational Advances and Strategic Challenges — Europe PMC PMID:42794948 — Europe PMC (en), https://europepmc.org/article/MED/42794948 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e1ca8dd93bc (Metraipolis archive dc_4e1ca8dd93bc, sha256 5280b558a6cfcfaeb089db219c6bd95190d86c3e7eb66f032734305ea3526fa4)

BibTeX

@misc{dc4e1ca8dd93bc,
  title = {Biomimetic Nanocarriers for Glioblastoma Therapy: Translational Advances and Strategic Challenges — Europe PMC PMID:42794948},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794948},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e1ca8dd93bc; sha256 5280b558a6cfcfaeb089db219c6bd95190d86c3e7eb66f032734305ea3526fa4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794948. Agents can read the archived copy with the MCP tool read_document.